First medicine targeting BRCA mutations to show clinical benefit in adjuvant setting
WILMINGTON, Del.--(BUSINESS WIRE)--
AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, today announced
HP Inc (NYSE:HPQ) announced an FY23 Future Ready Transformation plan, driving significant structural cost savings through digital transformation, portfolio optimization,…